Symbiopharm Laboratoriessp. z o.o.

Activities of head office and holding companies, excluding financial holding companies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-07-28
Share capital
5 000,00 PLN
Registered address
160, 38-120 Nowa Wieś, Poland

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 185.63kMedianUSD 24.37kAverageUSD 8.28m
Net profit
This companyUSD 185.24kMedianUSD 231.21AverageUSD 658.78k
Operating costs
This companyUSD 390.63MedianUSD 10.70kAverageUSD 10.19m
Assets
This companyUSD 441.96kMedianUSD 80.00kAverageUSD 15.16m

Industry

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Krok — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Paweł Krok (53)
100$1,350.62100%

Beneficial owners

Person
Paweł Krok (53)

Competitors

Name
SDCsp. z o.o. + limited partnership
MPP 1sp. z o.o.
Warwin Groupsp. z o.o.
Alba Investmentssp. z o.o.
Planet B2bS.A.
Atneo Advisory Groupsp. z o.o.
Radaway Holdingsp. z o.o.
Maxitosp. z o.o.
Moryń Companysp. z o.o.
ROKAsp. z o.o.

Change history

DateEvent
2020-08-04Name change
2020-07-28Entered in the register

FAQ

Last updated: 2026-09-25